Company Profile of Zhejiang regen chemical co., ltd.

Zhejiang Regen Chemical Co., Ltd. is located in Jiaojiang Pharmaceutical zone, Taizhou City, Zhejiang Province, covering an area of 50 acres. The factory built in the seaside, like a garden with green spaces surrounded. Regen sets on the southeast coast of Zhejiang Province, with convenient transportation, which expressways, railways, seaports and airports leading to all parts of the country. Regen is devoted to supplying pharmaceutical materials and special chemicals. Pharmaceutical materials including Apixaban, Rivaroxaban, Linagliptin, Fluoxetine, Lercanidipine and related intermediates. Special chemicals like piroctone olamine (PO), zinc pyrithione (ZPT), copper pyrithione (CPT), etc. Revenue is over 30 million dollars. Regen is a national high-tech enterprise, gathering more than 200 high-quality staff, including more than 50 professional and technical personnel, and has a provincial-level special chemical pharmaceutical R&D center. The company has complete chemical production equipments and three-waste treatment facilities, with a factory building of more than 10,000 square meters and fixed assets over 10 million dollars. Regarding quality as the foundation of establishment, Regen has various analytical devices such as liquid chromatography, gas chromatography, atomic absorption spectroscopy, and microbial detection, and get ISO9001 quality system certification. Since its establishment in 1993, Regen takes technological innovation as its engine, opening up new fields constantly and achieving fruitful results. Relying on advanced technology and excellent quality, Regen has entered into the supply chain of three international innitial pharmaceutical groups, and has also become the suppliers of more than a dozen international companies in the cleaning, coatings, and sterilization industries. It is our greatest wish to let Regen Made go to the world. We sincerely welcome friends on domestic and abroad to communicate and cooperate with us to create brilliant future.